Add to ORKGIron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysi
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
Background: One of the main complications of chronic kidney disease is anemia. Disorders of iron hom...
Background and objectives: Assessments of iron stores by serum iron saturation ratio (ISAT) and ferr...
Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease p...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure ...
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidne...
Background Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an ery...
Background. Erythropoiesis-stimulating agents (ESAs) are frequently used to treat anaemia of chronic...
Producción CientíficaAfter relative erythropoietin deficiency, iron deficiency is the second most im...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
Background: One of the main complications of chronic kidney disease is anemia. Disorders of iron hom...
Background and objectives: Assessments of iron stores by serum iron saturation ratio (ISAT) and ferr...
Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease p...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
[[abstract]]BACKGROUND: A risk/benefit analysis of iron supplementation in pre-dialysis advanced chr...
Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure ...
Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidne...
Background Patients with non-dialysis-dependent chronic kidney disease (ND-CKD) often receive an ery...
Background. Erythropoiesis-stimulating agents (ESAs) are frequently used to treat anaemia of chronic...
Producción CientíficaAfter relative erythropoietin deficiency, iron deficiency is the second most im...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatme...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
[[abstract]]OBJECTIVE: Iron supplementation and erythropoietin stimulating agents (ESAs) are essenti...
Background: One of the main complications of chronic kidney disease is anemia. Disorders of iron hom...
Background and objectives: Assessments of iron stores by serum iron saturation ratio (ISAT) and ferr...